RE:RE:RE:Must be April Fools' Day?!?...
I was expecting more. This is a submission stage cancer drug valued below 50 mil, which has publicly stated that they are reviewing multiple offers from multiple partners. Surely you would expect there to be some immediate uptake when a partership, sale or BLA submission could happen any day. Instead the SP retreats on weak volume.